US Deflazacort Market: Pharmaceutical Innovation Opens New...

добавлена новая статья Другое

2026-08-28 12:45:52 -

US Deflazacort Market: Pharmaceutical Innovation Opens New Opportunities

The US deflazacort market is supported by the continued need for corticosteroid therapy in Duchenne muscular dystrophy (DMD), a rare progressive muscle disorder. Deflazacort is available in oral tablet and suspension formulations, providing treatment options for eligible patients. Growing attention to rare-disease management, expanded availability of generic formulations, and ongoing...

0 Комментарии 0 Поделились 116 Просмотры 0 предпросмотр